A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA)

Completed · Phase 2 · Has a placebo group

Conditions studied: Plantar Fasciitis

In brief

This study will assess the efficacy, safety, and tolerability of 2 different doses of collagenase clostridium histolyticum (CCH) (previously known as EN3835) compared to placebo.

Key facts

Study ID
NCT06169319
Run by
Endo USA Inc., a Keenova Therapeutics Company
People needed
231
Starts
2024-01-03
Expected to finish
2024-09-30
Last updated by the study team
2025-09-30

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.